Protalix Biotherapeutics Correlations

PLX Stock

USD 2.86 0.06 2.05%

The current 90-days correlation between Protalix Biotherapeutics and Coherus BioSciences is 0.11 (i.e., Average diversification). The correlation of Protalix Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Protalix Biotherapeutics Correlation With Market

Very weak diversification

The correlation between Protalix Biotherapeutics and DJI is 0.58 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Protalix Stock

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protalix Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Protalix Stock please use our How to Invest in Protalix Biotherapeutics guide.

Moving together with Protalix Stock

0.69	CMB	Cambium Bio	Pair Corr
0.73	6C1	CytomX Therapeutics	Pair Corr
0.65	DRTS	Alpha Tau Medical	Pair Corr
0.75	PYC	Physiomics Plc	Pair Corr
0.62	0P6S	Bayer AG NA	Pair Corr

Moving against Protalix Stock

0.81	VCYT	Veracyte	Pair Corr
0.57	OSE	OSE Pharma SA	Pair Corr
0.57	DRMA	Dermata Therapeutics	Pair Corr
0.56	CDIOW	Cardio Diagnostics	Pair Corr
0.52	RAC	Race Oncology	Pair Corr
0.41	VCEL	Vericel Corp Ord	Pair Corr
0.84	BIM	Biomerieux SA	Pair Corr
0.8	XE9	Xencor Inc	Pair Corr
0.67	VKTX	Viking Therapeutics	Pair Corr
0.67	VRAX	Virax Biolabs Group	Pair Corr
0.66	DYAI	Dyadic International	Pair Corr
0.64	VSTM	Verastem	Pair Corr
0.59	DWTX	Dogwood Therapeutics	Pair Corr
0.56	XE7C	Cardiff Oncology	Pair Corr

Related Correlations Analysis

	SLS	CHRS	IVVD	TARA	GNFT	CDXS	OABI	NTHI	MDWD	SGMO
SLS		0.7	-0.18	-0.1	0.92	-0.38	0.23	0.23	-0.21	-0.35	SLS
CHRS	0.7		-0.6	0.36	0.81	-0.63	0.0	0.39	-0.25	-0.3	CHRS
IVVD	-0.18	-0.6		-0.32	-0.34	0.6	0.41	-0.57	0.29	0.07	IVVD
TARA	-0.1	0.36	-0.32		0.01	-0.49	-0.18	-0.1	-0.2	-0.13	TARA
GNFT	0.92	0.81	-0.34	0.01		-0.52	0.12	0.29	-0.21	-0.41	GNFT
CDXS	-0.38	-0.63	0.6	-0.49	-0.52		0.31	-0.18	0.28	0.26	CDXS
OABI	0.23	0.0	0.41	-0.18	0.12	0.31		-0.13	0.3	0.12	OABI
NTHI	0.23	0.39	-0.57	-0.1	0.29	-0.18	-0.13		0.06	0.13	NTHI
MDWD	-0.21	-0.25	0.29	-0.2	-0.21	0.28	0.3	0.06		0.32	MDWD
SGMO	-0.35	-0.3	0.07	-0.13	-0.41	0.26	0.12	0.13	0.32		SGMO
	SLS	CHRS	IVVD	TARA	GNFT	CDXS	OABI	NTHI	MDWD	SGMO

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GNFT	+ 0.92	SLS
GNFT	+ 0.81	CHRS
CHRS	+ 0.7	SLS
CDXS	+ 0.6	IVVD
OABI	+ 0.41	IVVD
NTHI	+ 0.39	CHRS

High negative correlations

CDXS	- 0.63	CHRS
IVVD	- 0.6	CHRS
NTHI	- 0.57	IVVD
CDXS	- 0.52	GNFT
CDXS	- 0.49	TARA
SGMO	- 0.41	GNFT

Risk-Adjusted Indicators

There is a big difference between Protalix Stock performing well and Protalix Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Protalix Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SLS	5.47	1.54	0.24	3.38	5.01	(6.30)	14.94	(8.17)	34.72
CHRS	4.80	0.48	0.08	0.35	5.94	(5.11)	10.34	(7.35)	41.11
IVVD	4.94	0.22	0.03	(0.47)	5.21	(5.83)	11.11	(7.07)	46.37
TARA	3.86	0.70	0.13	2.77	4.53	(4.54)	11.78	(7.72)	39.96
GNFT	3.17	0.65	0.12	(3.17)	3.86	(3.71)	7.34	(7.71)	25.18
CDXS	3.75	(0.44)	0.00	(13.99)	0.00	0.00	6.21	(7.74)	22.77
OABI	2.55	0.15	0.07	0.16	2.55	(3.26)	7.51	(5.31)	15.55
NTHI	5.24	0.02	0.03	0.07	7.29	(5.54)	9.99	(11.89)	41.97
MDWD	1.87	(0.07)	0.00	(0.07)	0.00	0.00	3.79	(4.40)	14.07
SGMO	4.58	(0.27)	0.00	(0.04)	0.00	0.00	9.52	(7.14)	73.25

Protalix Biotherapeutics Corporate Executives

Elected by the shareholders, the Protalix Biotherapeutics' board of directors comprises two types of representatives: Protalix Biotherapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Protalix. The board's role is to monitor Protalix Biotherapeutics' management team and ensure that shareholders' interests are well served. Protalix Biotherapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Protalix Biotherapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Gilad Mamlok

Senior CFO

Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC